Current and New Treatments of Photodamaged Skin

ABSTRACT

Patients with photodamaged skin need guidance in selecting treatment plans that optimize outcomes, minimize downtime, and reduce adverse effects. The gold standard among cosmeceuticals is the topical retinoids, such as tretinoin. A topical formulation of folic acid and creatine appears to be a viable treatment option for the treatment of photodamaged skin. The use of specific topical cosmeceuticals in combination with nonablative photorejuvenation is recommended in choosing modalities that address the concerns of the patient. A combination of intense pulsed light (IPL), low-intensity diode light, and biostimulating drugs has been shown to provide results superior to those of IPL alone for photorejuvenation. Photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) is the treatment of choice for type C photodamage. Low-strength 5-ALA (1 to 2%) applied several times, every 10 to 15 minutes, and incubated for 30 to 60 minutes with 550 to 630 nm, 530 to 1200 nm, or 570 to 1200 nm light activation improved hyperpigmented lesions, skin smoothing, and skin elasticity with high patient satisfaction. The use of 0.5% liposome-encapsulated 5-ALA spraying has been shown to be an alternative to 20% 5-ALA in a cream base in patients undergoing photorejuvenation. Adipose-derived stem cells and their derived secretory factors may have potential as treatments of photodamage.

KEYWORDS

Cosmeceutical - photodamage - photorejuvenation - photodynamic therapy

REFERENCES

• 1 Bitter P H. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments.  Dermatol Surg. 2000;  26 835-842; discussion 843
• 2 Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light.  Dermatol Surg. 2001;  27 627-631 discussion 632
• 3 Dover J S, Bhatia A C, Stewart B, Arndt K A. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging.  Arch Dermatol. 2005;  141 1247-1252
• 4 Rokhsar C K, Lee S, Fitzpatrick R E. Review of photorejuvenation: devices, cosmeceuticals, or both?.  Dermatol Surg. 2005;  31(9 Pt 2) 1166-1178; discussion 1178
• 5 Griffiths C E. Drug treatment of photoaged skin.  Drugs Aging. 1999;  14 289-301
• 6 Choi C M, Berson D S. Cosmeceuticals.  Semin Cutan Med Surg. 2006;  25 163-168
• 7 Kang S, Leyden J J, Lowe N J et al.. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.  Arch Dermatol. 2001;  137 1597-1604
• 8 Rabello-Fonseca R M, Azulay D R, Luiz R R, Mandarim-de-Lacerda C A, Cuzzi T, Manela-Azulay M. Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication.  J Eur Acad Dermatol Venereol. 2009;  23 115-123
• 9 Fitzpatrick R E, Rostan E F. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage.  Dermatol Surg. 2002;  28 231-236
• 10 Humbert P G, Haftek M, Creidi P et al.. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo.  Exp Dermatol. 2003;  12 237-244
• 11 Sadick N S. Cosmeceuticals. Their role in dermatology practice.  J Drugs Dermatol. 2003;  2 529-537
• 12 Kligman A M. The computability of combinations of glycolic acid and tretinoin in acne and photodamaged facial skin.  J Geriatr Dermatol. 1995;  3(Suppl A) 25A-28A
• 13 Ignotz R A, Endo T, Massagué J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta.  J Biol Chem. 1987;  262 6443-6446
• 14 Fitzpatrick R E, Rostan E F. Reversal of photodamage with topical growth factors: a pilot study.  J Cosmet Laser Ther. 2003;  5 25-34
• 15 Lupo M P. Cosmeceutical peptides.  Dermatol Surg. 2005;  31(7 Pt 2) 832-836; discussion 836
• 16 Rendon M I, Gaviria J I. Review of skin-lightening agents.  Dermatol Surg. 2005;  31(7 Pt 2) 886-889; discussion 889
• 17 Draelos Z D. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.  Dermatol Surg. 2005;  31(7 Pt 2) 799-804
• 18 Knott A, Koop U, Mielke H et al.. A novel treatment option for photoaged skin.  J Cosmet Dermatol. 2008;  7 15-22
• 19 Janjua R, Munoz C, Gorell E et al.. A two-year, double-blind, randomized placebo-controlled trial of oral green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin.  Dermatol Surg. 2009;  35 1057-1065
• 20 Trelles M A, Allones I, Velez M. Non-ablative facial skin photorejuvenation with an intense pulsed light system and adjunctive epidermal care.  Lasers Med Sci. 2003;  18 104-111
• 21 Fournier N, Fritz K, Mordon S. Use of nonthermal blue (405- to 420-nm) and near-infrared light (850- to 900-nm) dual-wavelength system in combination with glycolic acid peels and topical vitamin C for skin photorejuvenation.  Dermatol Surg. 2006;  32 1140-1146
• 22 Mezzana P. “Multi Light and Drugs”: a new technique to treat face photoaging. Comparative study with photorejuvenation.  Lasers Med Sci. 2008;  23 149-154
• 23 Weiss R A, Weiss M A, Beasley K L. Rejuvenation of photoaged skin: 5 years results with intense pulsed light of the face, neck, and chest.  Dermatol Surg. 2002;  28 1115-1119
• 24 Kennedy J C, Pottier R H, Pross D C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.  J Photochem Photobiol B. 1990;  6 143-148
• 25 Zakhary K, Ellis D AF. Applications of aminolevulinic Acid-based photodynamic therapy in cosmetic facial plastic practices.  Facial Plast Surg. 2005;  21 110-116
• 26 Tierney E, Barker A, Ahdout J, Hanke C W, Moy R L, Kouba D J. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging.  Dermatol Surg. 2009;  35 725-746
• 27 Nestor M S, Gold M H, Kauvar A N et al.. The use of photodynamic therapy in dermatology: results of a consensus conference.  J Drugs Dermatol. 2006;  5 57-71
• 28 Alster T S, Tanzi E L, Welsh E C. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study.  J Drugs Dermatol. 2005;  4 35-38
• 29 Gold M H, Bradshaw V L, Boring M M, Bridges T M, Biron J A. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage.  Dermatol Surg. 2006;  32 795-801; discussion 801–803
• 30 Marmur E S, Phelps R, Goldberg D J. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study.  J Cosmet Laser Ther. 2005;  7 21-24
• 31 Key D J. Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging.  Cosmetic Dermatol. 2005;  18 31-36
• 32 Zane C, Capezzera R, Sala R, Venturini M, Calzavara-Pinton P. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin.  Lasers Surg Med. 2007;  39 203-209
• 33 Ruiz-Rodriguez R, López L, Candelas D, Zelickson B. Enhanced efficacy of photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation.  J Drugs Dermatol. 2007;  6 818-820
• 34 Lowe N J, Lowe P. Pilot study to determine the efficacy of ALA-PDT photo-rejuvenation for the treatment of facial ageing.  J Cosmet Laser Ther. 2005;  7 159-162
• 35 Orringer J S, Hammerberg C, Hamilton T et al.. Molecular effects of photodynamic therapy for photoaging.  Arch Dermatol. 2008;  144 1296-1302
• 36 Serrano G, Lorente M, Reyes M et al.. Photodynamic therapy with low-strength ALA, repeated applications and short contact periods (40–60 minutes) in acne, photoaging and vitiligo.  J Drugs Dermatol. 2009;  8 562-568
• 37 Bjerring P, Christiansen K, Troilius A, Bekhor P, de Leeuw J. Skin fluorescence controlled photodynamic photorejuvenation (wrinkle reduction).  Lasers Surg Med. 2009;  41 327-336
• 38 Christiansen K, Bjerring P, Troilius A. 5-ALA for photodynamic photorejuvenation—optimization of treatment regime based on normal-skin fluorescence measurements.  Lasers Surg Med. 2007;  39 302-310
• 39 Lee M W. Novel 3-in-1 wavelength light source for photorejuvenation.  J Drugs Dermatol. 2008;  7 335-339
• 40 Sadick N S. A study to determine the efficacy of a novel handheld light-emitting diode device in the treatment of photoaged skin.  J Cosmet Dermatol. 2008;  7 263-267
• 41 Kim W-S, Park B-S, Sung J H. Protective role of adipose-derived stem cells and their soluble factors in photoaging.  Arch Dermatol Res. 2009;  301 329-336